InsidersTradesSigma
Follow the JW (Cayman) Therapeutics Co. Ltd - B stock price and the full management transaction log of the company, a listed equity based in Hong Kong. Shares are quoted on HK HK, under the authority of HKEX. Market capitalisation: €98.9m. The latest transaction was disclosed on 22 May 2026 (Purchase). Among the most active insiders: TIAN FENG. The full history is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
JW (Cayman) Therapeutics Co. Ltd - B is a company focused on developing innovative therapies. It concentrates on treatments for serious diseases and unmet medical conditions.